Did MEI/Kyowa Kirin Beat The PI3K Tolerability Trap?

Zandelisib Shows Unexpectedly Positive Data

 
• By Alaric DeArment
Snails on the athletic track moves the finish line (By Sergey Lavrentev. Shutterstock 463225937)
MEI/Kyowa Kirin's zandelisib appears to pull ahead of other PI3K-delta inhibitors on efficacy and safety • Source: Shutterstock

More from Anticancer

More from Therapeutic Category